![Novo Nordisk to acquire Forma Therapeutics and expand presence in sickle cell disease and rare blood disorders | Business Wire Novo Nordisk to acquire Forma Therapeutics and expand presence in sickle cell disease and rare blood disorders | Business Wire](https://mms.businesswire.com/media/20220901005393/en/1559342/23/Forma_Therapeutics-%28002%29.jpg)
Novo Nordisk to acquire Forma Therapeutics and expand presence in sickle cell disease and rare blood disorders | Business Wire
![Novo Nordisk A focused global healthcare company with biotech expertise Investor Presentation Spring ppt download Novo Nordisk A focused global healthcare company with biotech expertise Investor Presentation Spring ppt download](https://slideplayer.com/22/6352720/big_thumb.jpg)
Novo Nordisk A focused global healthcare company with biotech expertise Investor Presentation Spring ppt download
![Novo Nordisk and the University of Toronto announce joint 200 DKK million investment to address diabetes and chronic disease prevention Novo Nordisk and the University of Toronto announce joint 200 DKK million investment to address diabetes and chronic disease prevention](https://mma.prnewswire.com/media/1443120/Novo_Nordisk_Canada_Inc__Novo_Nordisk_and_the_University_of_Toro.jpg?p=facebook)
Novo Nordisk and the University of Toronto announce joint 200 DKK million investment to address diabetes and chronic disease prevention
Novo Nordisk announces Saxenda® (liraglutide [rDNA origin] injection) is now commercially available in the United States
![Novo Nordisk A focused global healthcare company with biotech expertise Investor Presentation Spring ppt download Novo Nordisk A focused global healthcare company with biotech expertise Investor Presentation Spring ppt download](https://slideplayer.com/4828055/15/images/slide_1.jpg)